Medical News

RSS

UAE Exchange Shamshabad branch actively participated in Pulse Polio immunization program

"Children's Health, The Nation's Wealth" is the motto that all the staff of UAE Exchange Shamshabad branch held close to their heart. The second phase of the Pulse Polio Immunization program, was held across India on February 24th.

5 Mar 2013

Workers with rheumatoid arthritis incur increased health-related costs

Workers with rheumatoid arthritis (RA) incur increased direct and indirect health-related costs, reports a study in the March Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

5 Mar 2013

Avedro announces completion of $43M Series D financing

Avedro, Inc. announced today the completion of a $43 million Series D financing led by Abingworth along with a significant investment by Third Point.

5 Mar 2013

Dr. Reddy's launches generic Zometa

Dr. Reddy's Laboratories announced today that it has launched Zoledronic Acid Injection (4 mg/5 mL), a bioequivalent generic version of Zometa® (zoledronic acid) 4 mg/5 mL Injection in the US market on March 4, 2013, following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Zoledronic Acid Injection (4 mg/5 mL).

5 Mar 2013

Overall risk of infection associated with most neuroangiographic procedures is very low

Patients undergoing cerebral angiography and neurointerventional procedures on the brain are at very low risk of infection-even without preventive antibiotics, reports a study in the March issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

5 Mar 2013

People with variations in FTO gene could be at increased risk of melanoma

The research shows that people with particular variations in a stretch of DNA within the FTO gene, called intron 8, could be at greater risk of developing melanoma.

5 Mar 2013

HCV and HIV co-infected patients achieve early treatment success with faldaprevir, PegIFN/RBV

Interim study results from STARTversoTM 4 presented today at CROI+ show that 80 percent of hepatitis C (HCV) patients also infected with HIV achieved early treatment success with faldaprevir (BI 201335) combined with pegylated interferon and ribavirin (PegIFN/RBV).

5 Mar 2013

Acadia proposes $150M in senior unsecured notes due 2021

Acadia Healthcare Company, Inc. today announced that it is proposing to issue $150 million in senior unsecured notes due 2021 in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended.

5 Mar 2013

Biogen announces FDA acceptance of rFIXFc BLA for treatment of hemophilia B

Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application (BLA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B and granted the company a standard review timeline.

5 Mar 2013

Results from Pfizer’s Prevnar 13 Phase 3 study on HIV

Pfizer Inc. presented today the results from a Phase 3 study demonstrating the immunogenicity, tolerability and safety of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine Diphtheria CRM197 Protein)in adults infected with human immunodeficiency virus (HIV).

5 Mar 2013

WomanCare Global, Evofem enter strategic alliance

Evofem announced today that it has entered into a strategic alliance with WomanCare Global. Through this alliance, WomanCare Global will provide sales, marketing and global distribution for a selection of Evofem's products, including Softcup and Amphora.

4 Mar 2013

Screening colonoscopy associated with reduced advanced colorectal cancer diagnoses

A new study led by a researcher at the Perelman School of Medicine at the University of Pennsylvania adds support to current medical recommendations stating that screening colonoscopy substantially reduces an average-risk adult's likelihood of being diagnosed with advanced colorectal cancer (CRC) in either the right or left side of the colon.

4 Mar 2013

OPKO Health acquires Cytochroma

OPKO Health, Inc. announced that it has completed the acquisition of Cytochroma Inc. Cytochroma's lead products include CTAP101 Capsules, a vitamin D prohormone to treat secondary hyperparathyroidism (SHPT) in patients with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency, and Fermagate Tablets, a new and potent non-absorbed phosphate binder to treat hyperphosphatemia in CKD patients on chronic hemodialysis.

4 Mar 2013

Wiley announces publication of Essential Reproduction, 7th Edition

Wiley is pleased to announce the publication of Essential Reproduction, 7th Edition, a fully-revised and updated edition of the best-selling introduction to the study of reproduction.

4 Mar 2013

Exercise during pregnancy can reduce rate of cesarean deliveries in healthy pregnant women

Researchers at the Universidad Politécnica de Madrid have found that regular and supervised exercise by experts during pregnancy can reduce the rate of instrumental and cesarean deliveries in healthy pregnant women.

4 Mar 2013

Nautilus fourth quarter net sales increase 8.4% to $65.0 million

Nautilus, Inc. today reported its unaudited operating results for the fourth quarter and full year ended December 31, 2012.

4 Mar 2013

FDA approves Tenaxis Medical’s ArterX Surgical Sealant

Tenaxis Medical, Inc., a medical device company focused on the development of functionally designed surgical sealants has received FDA approval to bring its innovative ArterX Surgical Sealant to the market.

4 Mar 2013

Viewpoints: Daschle, Frist urge Senate to confirm CMS chief; 'Insane' incentives in health law; Medicaid does better job than private insurance so why change it?

Imagine a large company operating for seven years without a CEO. A company with a product that accounts for more than 15 percent of our nation's gross domestic product. A company implementing the largest national effort at reform since its creation. A company set to gain an additional 30 million customers in the next year. Unfathomable.

4 Mar 2013

HIV infection may increase risk of acute myocardial infarction

A study that analyzed data from more than 82,000 veterans suggests that infection with the human immunodeficiency virus (HIV) was associated with an increased risk of acute myocardial infarction (AMI, heart attack) beyond what is explained by recognized risk factors, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.

4 Mar 2013